N2Jenomics Lab Pvt. Ltd. provides high-quality genotyping services using the Infinium Global Diversity Array-8 (GDA-8) v1.0. Powered by Illumina's advanced microarray technology, the platform enables comprehensive genome-wide analysis for population genetics, polygenic risk score (PRS) research, pharmacogenomics, and cytogenetic studies. Featuring approximately 1.8 million multi-ethnic genetic markers, GDA-8 delivers accurate, high-resolution genotyping across diverse populations.
| Parameter | Specification |
|---|---|
| Assay Chemistry | Infinium™ LCG Chemistry |
| Platform / Instrument | Illumina iScan® System |
| Samples per BeadChip | 8 Samples |
| Fixed Marker Content | 1,825,277 Genome-wide Markers |
| Custom Add-on Capacity | Up to 175,000 Custom Markers |
| DNA Input Requirement | 200 ng Genomic DNA per Sample |
| Maximum Throughput (Single iScan) | Approximately 1,728 Samples per Week |
| Scanning Time | Approximately 4.4 Minutes per Sample |
| Workflow Duration | Standard 3-Day Infinium™ Workflow |
| Variant Detection | Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Loss of Heterozygosity (LOH), Chromosomal Abnormalities, and Structural Variants |
| Compatible Sample Types | Whole Blood, FFPE Tissue, Buccal Swabs, and Saliva |
| Nucleic Acid Input | Genomic DNA |
| Technology | High-Density Microarray-Based Genome-Wide Genotyping |
| Gene Coverage | Targeted analysis of 4,800+ clinically and biologically relevant genes with an average genomic resolution of approximately 1.5 Mb |
| Analytical Performance | Typical Call Rate: ~99.7% • Reproducibility: ~99.99% |
| Optional Configuration – Cytogenetics-8 | Approximately 1.8 million probes plus 160,000 supplemental probes covering more than 4,800 genes for enhanced cytogenetic analysis |
| Optional Configuration – Enhanced PGx-8 | More than 1.9 million markers with expanded pharmacogenomics (PGx) content while retaining the complete Global Diversity Array backbone |
| Available Kit Sizes | 16, 48, 96, or 384 Samples per Kit |
| Automation Compatibility | Supports Automated Array Loaders and Robotic Liquid-Handling Systems |
Related platform — Infinium Global Screening Array-24 (GSA-24)
For scalable, cost effective population-level genotyping, consider GSA-24, a 24-sample Infinium HTS array that combines multiethnic genome-wide content with clinical research variants. (Research use only)
Learn more → GSA-24 analysis service.
Use the multiethnic scaffold for cross-population imputation, ancestry inference, and fine-mapping in global cohorts. This platform replaced Illumina's Multi-Ethnic arrays to improve coverage and portability across studies.
Run GWAS with ~1.8 M markers to detect trait-associated variants at scale. The array was selected for NIH All of Us, supporting very large cohorts.
Derive PRS using genome-wide content and integrated array analysis software; cloud workflows are supported.
Choose Infinium Global Diversity Array with Cytogenetics-8 for genome-wide CNV and LOH assessment, with added exonic probes across >4800 genes. Average cytogenetic resolution is reported around the megabase scale.
Select Infinium Global Diversity Array with Enhanced PGx-8 to expand drug-gene content while retaining GDA-8's multiethnic backbone for PRS and disease studies.
GDA-8 supports high weekly throughput suitable for population programs and longitudinal resources.

At N2Jenomics Lab Pvt. Ltd., we provide a comprehensive end-to-end bioinformatics workflow for Infinium Global Diversity Array-8 (GDA-8) data. Our validated analysis pipeline transforms raw array data into high-quality, research-ready datasets with detailed reports to support population genetics, GWAS, PRS, cytogenetics, and pharmacogenomics studies.
At N2Jenomics Lab Pvt. Ltd., we combine advanced Illumina genotyping technology with expert scientific support to deliver accurate, scalable, and research-ready Infinium Global Diversity Array-8 (GDA-8) solutions. From sample processing to bioinformatics interpretation, our experienced team ensures high-quality results tailored to your research objectives.
| Category | Requirement | Notes |
|---|---|---|
| Sample types | Tissue, cells, FFPE, genomic DNA | Provide purified DNA where possible |
| DNA purity | OD260/280: 1.7–2.1; clear electrophoresis bands; > 10 kb; no obvious degradation | High-molecular-weight DNA preferred |
| DNA concentration | ≥ 50 ng/µL | Measured by fluorometry or spectrophotometry |
| Total DNA amount | ≥ 1 µg (high-quality samples acceptable down to 500 ng) | Send extra to cover QC/repeats if possible |
| Solvent / buffer | TE or ddH₂O | Nuclease-free, no carriers or detergents |
| Container | 1.5 mL microcentrifuge tube or 96-well plate | Use sealing film; ensure tight caps/heat seals |
| Short-term storage | 2–8 °C | Avoid freeze–thaw cycles |
| Long-term storage | ≤ −20 °C | −80 °C acceptable for archiving |
| Local transport | Cold packs/blue ice, 2–8 °C | Pack to prevent tube damage |
| Long-distance transport | Dry ice, ≤ −20 °C | Include absorbent material and manifest |
Tip: Label tubes or plate wells with unique IDs matching the sample manifest.
Answer: The Infinium Global Diversity Array-8 (GDA-8) is a high-density genotyping microarray containing approximately 1.83 million genetic markers. It is designed for comprehensive genome-wide association studies (GWAS), population genetics, ancestry research, and genetic diversity analysis across multiple ethnic populations.
Answer: The Enhanced PGx-8 version includes all the standard GDA content while adding an expanded set of pharmacogenomic (PGx) markers, with over 1.9 million total markers. It is the preferred choice for studies investigating drug response, precision medicine, and pharmacogenomics.
Answer: The Cytogenetics-8 array is recommended when your research requires both SNP genotyping and genome-wide copy number variation (CNV) and loss of heterozygosity (LOH) analysis. It is specifically optimized for cytogenetic and constitutional genomics applications.
Answer: Microarray technology enables high-resolution detection of copy number variations (CNVs), chromosomal deletions, duplications, and allelic imbalance across the genome. These insights are valuable for clinical genetics, cytogenetics, and genotype-phenotype correlation studies.
Answer: Yes. The GDA-8 is designed with a multi-ethnic genomic backbone, making it well suited for polygenic risk score (PRS) development, genotype imputation, and cross-population genetic studies.
Answer: We provide comprehensive deliverables based on your project requirements, including raw IDAT files, GTC files, Illumina manifest files, genotype reports, quality control summaries, CNV analysis (where applicable), and analysis-ready datasets.
Answer: Yes. Illumina offers add-on content and "+" kit options that allow additional genetic loci to be incorporated while maintaining the standard 8-sample BeadChip format. We can help select the most appropriate configuration for your research objectives.
Answer: Absolutely. The GDA-8 is specifically developed for large cohort studies, biobanks, population genomics, ancestry research, and multi-ethnic genome-wide association studies, offering high marker density and broad genomic coverage.
Answer: Yes. The Infinium Global Diversity Array-8 is Illumina's recommended successor to the earlier Multi-Ethnic Global Array, providing improved genomic coverage and enhanced performance across diverse populations.
Answer: The Infinium Global Diversity Array v1.0 BeadChip contains approximately 1,825,277 fixed genetic markers, enabling high-resolution genome-wide analysis.
Answer: The Cytogenetics-8 array focuses on CNV and LOH detection alongside SNP genotyping, whereas the Enhanced PGx-8 array expands pharmacogenomic marker coverage while retaining the core GDA content for disease association and population genetics research.
Answer: We provide all essential files for downstream bioinformatics analysis, including Illumina manifest files, cluster files, raw IDAT files, GTC files, genotype datasets, quality control reports, CNV outputs (where applicable), and other project-specific analysis deliverables.